Total Payments
$101,028
2024 Payments
$35,245
Companies
16
Transactions
107
Payment Breakdown by Category
Consulting$43,736 (43.3%)
Other$25,050 (24.8%)
Research$19,544 (19.3%)
Travel$9,200 (9.1%)
Food & Beverage$3,498 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $43,736 | 14 | 43.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,800 | 6 | 22.6% |
| Unspecified | $19,544 | 16 | 19.3% |
| Travel and Lodging | $9,200 | 31 | 9.1% |
| Food and Beverage | $3,498 | 39 | 3.5% |
| Honoraria | $2,250 | 1 | 2.2% |
Payments by Type
General
$81,484
91 transactions
Research
$19,544
16 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $40,803 | 42 | $0 (2024) |
| Genentech, Inc. | $22,830 | 19 | $0 (2023) |
| F. Hoffmann-La Roche AG | $15,404 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $9,267 | 6 | $0 (2021) |
| AQUESTIVE THERAPEUTICS, INC. | $4,140 | 2 | $0 (2022) |
| Kaleo, Inc. | $3,257 | 9 | $0 (2017) |
| INSYS Therapeutics Inc | $1,760 | 2 | $0 (2018) |
| Hikma Pharmaceuticals USA | $1,500 | 1 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $1,260 | 1 | $0 (2023) |
| Phadia US Inc. | $329.78 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,245 | 32 | Genentech USA, Inc. ($27,836) |
| 2023 | $29,425 | 29 | Genentech USA, Inc. ($12,890) |
| 2022 | $5,886 | 7 | AQUESTIVE THERAPEUTICS, INC. ($4,140) |
| 2021 | $6,540 | 3 | Novartis Pharmaceuticals Corporation ($6,540) |
| 2020 | $11,019 | 8 | Genentech, Inc. ($8,296) |
| 2019 | $7,552 | 11 | Genentech, Inc. ($7,387) |
| 2018 | $1,100 | 4 | INSYS Therapeutics Inc ($900.00) |
| 2017 | $4,261 | 13 | Kaleo, Inc. ($3,257) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Immunology | ||||||
| 10/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $44.46 | General |
| Category: Immunology | ||||||
| 09/30/2024 | F. Hoffmann-La Roche AG | Xolair (Biological) | — | In-kind items and services | $4,640.78 | Research |
| Study: SAFETY PROFILE OF XOLAIR IN THE POST MARKETING SETTING A SUBANALYSIS OF THE PROSPERO STUDY • Category: Immunology | ||||||
| 08/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $854.56 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $221.13 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $124.08 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Immunology | ||||||
| 06/30/2024 | F. Hoffmann-La Roche AG | Xolair (Biological) | — | In-kind items and services | $940.00 | Research |
| Study: Impact Of Food Allergy On Work Productivity And Healthcare Resource Use In Patients With Allergic Asthma Treated With Omalizumab • Category: Immunology | ||||||
| 06/30/2024 | F. Hoffmann-La Roche AG | Xolair (Biological) | — | In-kind items and services | $337.00 | Research |
| Study: Impact Of Food Allergy On Work Productivity And Healthcare Resource Use In Patients With Allergic Asthma Treated With Omalizumab • Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $276.91 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $276.81 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $123.18 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $98.95 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $62.55 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | Cash or cash equivalent | $11.15 | General |
| Category: Immunology | ||||||
| 06/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $461.25 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $442.55 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $177.96 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $112.86 | General |
| Category: Immunology | ||||||
| 05/07/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SAFETY PROFILE OF XOLAIR IN THE POST MARKETING SETTING A SUBANALYSIS OF THE PROSPERO STUDY | F. Hoffmann-La Roche AG | $5,802 | 3 |
| Effect of Omalizumab on Asthma Outcomes in Adolescents/Adults with Asthma and Food Allergy | F. Hoffmann-La Roche AG | $3,296 | 4 |
| Impact Of Food Allergy On Work Productivity And Healthcare Resource Use In Patients With Allergic Asthma Treated With Omalizumab | F. Hoffmann-La Roche AG | $2,768 | 3 |
| Effect of Omalizumab on Asthma Outcomes in Pediatric Patients with Asthma and Food Allergy | F. Hoffmann-La Roche AG | $2,325 | 3 |
| Hospitalizations and Emergency Department Visits Before and After Omalizumab Treatment in Patients With Asthma and Food Allergies | F. Hoffmann-La Roche AG | $1,214 | 1 |
About Dr. David Fleischer, MD
Dr. David Fleischer, MD is a Allergy & Immunology healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386724615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Fleischer, MD has received a total of $101,028 in payments from pharmaceutical and medical device companies, with $35,245 received in 2024. These payments were reported across 107 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($43,736).
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Pediatric Allergy/Immunology, Pediatrics
- Location Aurora, CO
- Active Since 10/17/2006
- Last Updated 12/04/2018
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1386724615
Products in Payments
- Xolair (Biological) $79,037
- XOLAIR (Biological) $9,267
- Auvi-Q (Drug) $3,129
- Epinephrine (Device) $1,500
- Epinephrine (Drug) $860.00
- ImmunoCAP (Device) $329.78
- DUPIXENT (Biological) $183.64
- Evzio (Drug) $128.07
- XEOMIN (Biological) $106.84
- Odactra (Drug) $59.77
- DUPIXENT (Drug) $40.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Aurora
Dr. Maureen Bauer, Md, MD
Allergy & Immunology — Payments: $10,020
Allergy & Immunology $10,020
Andrew Fontenot, Md, MD
Allergy & Immunology — Payments: $2,526
Allergy & Immunology $2,526
Dr. Anjeli Kalra, M.d, M.D
Allergy & Immunology — Payments: $2,182
Allergy & Immunology $2,182
Robert Rogers, M.d, M.D
Allergy & Immunology — Payments: $1,886
Allergy & Immunology $1,886
Allen Adinoff, Md, MD
Allergy & Immunology — Payments: $632.76
Allergy & Immunology $632.76
Louise Helander, Md, MD
Allergy & Immunology — Payments: $510.87
Allergy & Immunology $510.87